Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $33

Baird analyst Catherine Schulte maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $56 to $33.
byBenzinga Newsdesk
November 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst Catherine Schulte maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $56 to $33.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts